Phytoestrogens in menopausal women: A review of recent findings;Phytoœstrogènes chez la femme ménopausée

Medecine/Sciences

Volumn 19, Issue 10, 2003, Pages 1030-1038

  Dodin, Sylvie ^a   Blanchet, Claudine ^a   Marc, Isabelle ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PHYTOESTROGEN; ISOFLAVONE DERIVATIVE; LIPID; PLANT MEDICINAL PRODUCT;

BONE METABOLISM; BREAST CARCINOMA; CANCER RISK; CONCENTRATION RESPONSE; DRUG EFFICACY; ESTROGEN ACTIVITY; HORMONE SUBSTITUTION; HUMAN; MENOPAUSAL SYNDROME; REVIEW; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT PLANNING; AGED; BLOOD; BONE DENSITY; BREAST TUMOR; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CLINICAL TRIAL; FEMALE; MENOPAUSE; MIDDLE AGED; OSTEOPOROSIS; RISK FACTOR;

AGED; BONE DENSITY; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CLINICAL TRIALS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; ISOFLAVONES; LIPIDS; MENOPAUSE; MIDDLE AGED; OSTEOPOROSIS; PHYTOESTROGENS; PLANT PREPARATIONS; RISK FACTORS;

EID: 0141998680     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/200319101030     Document Type: Review

References (54)

1. OMS. Stratégie de l'OMS pour la médecine traditionnelle pour 2002-2005. Genève: Organisation mondiale de la Santé, 2002: 1-78.
2. Harris P, Rees R. The prevalence of complementary and alternative medicine use among the general population: a systematic review of the literature. Compl Ther Med 2000; 8: 88-96.
3. Eisenberg DM, Kessler RC, Van Rompay MI, et al. Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann Intern Med 2001; 135: 344-51.
4. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.
5. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002; 22: 19-34.
6. Lock M, Kaufert P, Gilbert P. Cultural construction of the menopausal syndrome: the Japanese case. Maturitas 1988; 10: 317-32.
7. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 2002; 137: 805-13.
8. Setchell KD, Brown NM, Zimmer-Nechemias L, et al. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am J Clin Nutr 2002; 76: 447-53.
9. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol 2002; 3: 364-73.
10. Anthony MS. Soy and cardiovascular disease: cholesterol lowering and beyond. J Nutr 2000; 130: 662S-3S.
11. Clarkson TB, Anthony MS, Morgan TM. Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens. J Clin Endocrinol Metab 2001; 86: 41-7.
12. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995; 333: 276-82.
13. Warren MP, Shortle B, Dominguez JE. Use of alternative therapies in menopause. Best Pract Res Clin Obstet Gynaecol 2002; 16: 411-48.
14. Lucas EA, Wild RD, Hammond LJ, et al. Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 2002; 87: 1527-32.
15. Lemay A, Dodin S, Kadri N, Jacques H, Forest JC. Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstet Gynecol 2002; 100: 495-504.
16. Uesugi T, Fukui Y, Yamori Y. Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal japarese women: a four-week study. J Am Coll Nutr 2002; 21: 97-102.
17. Wangen KE, Duncan AM, Merz-Demlow BE, et al. Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J Clin Endocrinol Metab 2000; 85: 3043-8.
18. Horn-Ross PL, John EM, Lee M, et al. Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am J Epidemiol 2001; 154: 434-41.
19. Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 2002; 23: 1491-6.
20. Shu XO, Jin F, Dai Q, et al. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 2001; 10: 483-8.
21. McMichael-Phillips DF, Harding C, Morton M, et al. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am J Clin Nutr 1998; 68: 1431S-1435S.
22. Hargreoves DF, Potten CS, Harding C, et al. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab 1999; 84: 4017-24.
23. Maskarinec G, Williams AE, Carlin L. Mammographic densities in a one-year isoflavone intervention. Eur J Cancer Prev 2003; 12: 165-9.
24. Baber RJ, Templeman C, Morton T, Kelly GE, West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999; 2: 85-92.
25. Dalais FS, Rice GE, Wahlqvist ML, et al. Effects of dietary phytoestrogens in postmenopausol women. Climacteric 1998; 1: 124-9.
26. Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women a multicenter, double-blind, randomized, placebo-controlled study. Menopause 2000; 7: 236-42.
27. St Germain A, Peterson CT, Robinson JG, Alekel DL. Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause 2001; 8: 17-26.
28. Knight DC, Howes JB, Eden JA. The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 1999; 2: 79-84.
29. Quella SK, Loprinzi CL, Barton DL, et al. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors. A North Central cancer treatment group trial. J Clin Oncol 2000; 18: 1068-74.
30. Han KK, Soares JM, Jr., Haidar MA, de Lima GR, Baracat EC. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet Gynecol 2002; 99: 389-94.
31. Murkies AL, Lombard C, Strauss BJ, Wilcox G, Burger HG, Morton MS. Dietary flour supplementotion decreases post-menopausal hot flushes effect of soy and wheat. Maturitas 1995; 21: 189-95.
32. Knight DC, Howes JB, Eden JA, Howes LG. Effects on menopausal symptoms and acceptability of isoflavone-containing soy powder dietary supplementation. Climacteric 2001; 4: 13-8.
33. Scambia G, Mango D, Signorile PG, et al. Clinical effects of a standardized soy extract in postmenopausal women a pilot study. Menopause 2000; 7: 105-11.
34. Van Patten CL, Olivotto IA, Chambers GK, et al. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer a randomized, controlled clinical trial. J Clin Oncol 2002; 20: 1449-55.
35. Kotsopoulos D, Dalais FS, Liang YL, McGrath BP, Teede HJ. The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric 2000; 3: 161-7.
36. Washburn S, Burke GL, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999; 6: 7-13.
37. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forici E, De Aloysio D. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998; 91: 6-11.
38. Brzezinski A, Adlercreutz H, Shaoul R, Rosler A, Shmueli A, Tanos Vea. Short-term effect of phytoestroger-rich diet on postmenopausal women. Menopouse 1997; 4: 89-94.
39. Baird DD, Umbach DM, Lansdell L, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995; 80: 1685-90.
40. Chiechi LM, Secreto G, D'Amore M, et al. Efficacy of a soy rich diet in preventing postmenopausal osteoporosis the Menfis randomized trial. Maturitas 2002; 42: 295-300.
41. Clifton-Bligh PB, Baber RJ, Fulcher GR, Nery ML, Moreton T. The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause 2001; 8: 259-65.
42. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 2000; 72: 844-52.
43. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. Soy protein and isoflavones their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998; 68: 1375S-9S.
44. Dai Q, Franke AA, Jin F, et al. Urinary excretion of phytoestrogens and risks of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 2002; 11: 815-21.
45. Pietinen P, Stumpf K, Mannisto S, Kataja V, Uusitupa M, Adlercreutz H. Serum enterolactone and risk of breast cancer a case-control study in eastern Finland. Cancer Epidemiol Biomarkers Prev 2001; 10: 339-44.
46. McCann SE, Moysich KB, Freudenheim JL, Ambrosone CB, Shields PG. The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women. J Nutr 2002; 132: 3036-41.
47. Zheng W, Dai Q, Custer LJ, et al. Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1999; 8: 35-40.
48. den Tonkelaar I, Keinan-Boker L, Veer PV, et al. Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001; 10: 223-8.
49. Murkies A, Dalais FS, Briganti EM, et al. Phytoestrogens and breast cancer in postmenopausal women a case control study. Menopause 2000; 7: 239-96.
50. Torres-Sanchez L, Lopez-Carrillo L, Lopez-Cervantes M, Rueda-Neria C, Wolff MS. Food sources of phytoestrogens and breast cancer risk in Mexican women. Nutr Cancer 2000; 37: 134-9.
51. Dai Q, Shu XO, Jin F, et al. Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer 2001; 85: 372-8.
52. Wu AH, Ziegler RG, Horn-Ross PL, et al. Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev 1996; 5: 901-6.
53. Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997; 350: 990-4.
54. Witte JS, Ursin G, Siemiatycki J, Thompson WD, Paganini-Hill A, Haile RW. Diet and premenopausal bilateral breast cancer a case-control study. Breast Cancer Res Treat 1997; 42: 243-51.